| Name | Title | Contact Details |
|---|---|---|
Erin Koehler |
Chief Strategy & Product Officer | Profile |
Our mission at Awair is to empower you with the knowledge, motivation, and confidence to be healthy and thrive in your environment.
OSCOR Inc. designs, develops, manufactures and markets a variety of highly specialized implantable cardiac pacing leads, venous access systems and diagnostic catheters. Oscor is also leveraging its proprietary lead technologies toward the development
Claimpay is a healthcare billing company that combines smart technology with billing expertise to manage a practices entire revenue process.
Electra-Med Corp is a Flint, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.